Erythema Toxicum Neonatorum

01Pathophysiology

Erythema toxicum neonatorum (ETN) is the most common benign pustular eruption in newborns, affecting roughly 30% to 70% of full-term neonates. Despite the alarming name, it is neither toxic nor dangerous.

The exact mechanism remains incompletely understood, but the prevailing theory centers on activation of the innate immune system in the neonatal period. After birth, the skin is exposed to the external environment for the first time. Commensal organisms begin to colonize hair follicles, and this triggers an immune reaction at the level of the pilosebaceous unit. This explains why the rash is follicular in distribution and why it does not appear on the palms and soles, which lack hair follicles.

The inflammatory infiltrate is predominantly eosinophilic. Eosinophils migrate to the superficial dermis and into the follicular epithelium, forming the characteristic sterile pustules. This eosinophilic infiltration is the direct reason why a Wright stain of the pustule contents reveals sheets of eosinophils rather than bacteria or neutrophils. Some neonates also show a mild peripheral eosinophilia on CBC, reflecting this systemic eosinophilic activation.

The lesions are evanescent, meaning they appear, resolve within hours, and then reappear at different sites. This migratory behavior is thought to reflect waves of immune activation across different follicular units as colonization progresses. The self-limiting nature of the condition (typically resolving within 1 to 2 weeks) corresponds to the maturation and downregulation of the neonatal innate immune response as the skin microbiome stabilizes.

The critical teaching point is that the pathophysiology directly explains why this condition is benign: it is a normal immunologic response to microbial colonization, not an infection. There is no pathogen to treat.

02Classification and Clinical Manifestation

ETN does not have formal disease stages or severity classifications. However, the morphology of individual lesions evolves, and exam vignettes may describe the rash at any point in this progression.

Distribution pattern:

Timing of onset:

03Diagnostic Workup

ETN is fundamentally a clinical diagnosis in the majority of cases. A healthy full-term neonate with the characteristic rash distribution, evanescent lesions, and sparing of palms and soles typically needs no laboratory workup at all.

When a vignette asks for the best initial test to confirm the diagnosis, the answer is a Wright stain (or Giemsa stain) of the pustule contents. The technique involves unroofing a pustule, smearing the contents onto a slide, and staining. The hallmark finding is a predominance of eosinophils, which distinguishes ETN from virtually every other neonatal pustular condition. Bacterial pustulosis shows neutrophils and organisms; HSV shows multinucleated giant cells on Tzanck prep.

There is no "gold standard" confirmatory test beyond the Wright stain because skin biopsy is never indicated for this benign condition. If a biopsy were performed (purely academic), it would show an eosinophilic infiltrate centered on the pilosebaceous unit, confirming the follicular nature of the process.

A Gram stain and culture are obtained only if there is genuine clinical concern for neonatal bacterial skin infection (e.g., if the infant appears ill, febrile, or the lesions are expanding with surrounding cellulitis). In ETN, the Gram stain is negative and cultures are sterile.

A CBC is not routinely necessary but may be ordered if the clinical picture is ambiguous. The finding of peripheral eosinophilia in an otherwise well-appearing neonate supports the diagnosis and argues against a bacterial process, which would produce neutrophilia and left shift.

The single most testable concept in this section: eosinophils on Wright stain = ETN. This is the one finding that locks in the diagnosis.

04Management and Treatment

Acute management: There is no acute management because ETN is not a disease requiring treatment. The "next best step" when presented with a classic ETN vignette is reassurance. This is the answer the exam is looking for. No creams, no ointments, no steroids, no antibiotics.

Parental counseling: Parents should be told that the rash is harmless, extremely common, not contagious, not caused by anything they did or failed to do, and will resolve on its own without scarring. They should avoid applying lotions, powders, or other topical products to the lesions, as these can cause irritation.

When to escalate: The only situation where management changes is when the presentation deviates from classic ETN. Red flags that should prompt further evaluation include:

• Vesicles grouped in clusters on an erythematous base (raises concern for neonatal HSV)

• Pustules with surrounding cellulitis or warmth (raises concern for staphylococcal infection)

• Infant who is febrile, lethargic, or feeding poorly (raises concern for sepsis)

• Onset after 2 weeks of age (less likely to be ETN; consider other diagnoses)

There are no contraindications to discuss because no medication is used. There are no drug interactions, no dose adjustments, and no follow-up labs required.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common way students get questions about ETN wrong is by overreacting to the rash and choosing an unnecessary workup or treatment. The exam vignette will describe a newborn covered in a dramatic-sounding rash with pustules, and the natural instinct is to order cultures, start antibiotics, or consult dermatology. The correct answer is almost always reassurance alone, provided the infant is well-appearing and full-term.

The second major trap is confusing ETN with transient neonatal pustular melanosis. Both are benign and self-limiting, and both occur in the neonatal period. The discriminators to memorize: ETN has eosinophils on Wright stain and an erythematous base; melanosis has neutrophils on Wright stain, a collarette of scale, and residual hyperpigmented macules. Melanosis is more often present at birth, while ETN more commonly appears after the first 24 hours.

The third trap involves neonatal HSV. An exam question may describe vesicles in a newborn and test whether you recognize when to worry. The key discriminator is the pattern: HSV vesicles are grouped and clustered, the infant may show systemic signs of illness, and the clinical context often includes maternal genital herpes or prolonged rupture of membranes. ETN lesions are scattered, evanescent, and the infant is well. Missing neonatal HSV has catastrophic consequences, so the exam tests whether you can tell the two apart.

The core competency being tested with ETN questions is pattern recognition of benign versus dangerous neonatal rashes, combined with the discipline to avoid unnecessary intervention. The exam wants to confirm that you can identify a well-appearing infant with a classic benign eruption and choose observation over treatment, while simultaneously recognizing the red flags that would demand urgent action.

Remember the anchoring facts: full-term, well-appearing, eosinophils, spares palms and soles, no treatment needed.